ALDERLEY ANALYTICAL LTD
Significant control: Synexa Life Sciences Ltd (75–100%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Alderley Analytical Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Alderley Analytical Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
ALDERLEY ANALYTICAL LTD is an active private limited company (company number 08665244) incorporated on 27 August 2013, registered in Macclesfield. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 December 2025, showing net assets of −£297k and cash of £192k, with 51 employees on average. Net assets fell 204% on the prior period (£284k). Across the last 3 periods on record the net-asset trend is falling.
By net assets it sits in the bottom quarter of 138 comparable companies in Manchester (median £436, upper quartile £124k).
Ownership and control
- Synexa Life Sciences Ltd
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 27 August 201313 yrs ago
- Next accounts due
- 30 September 2027in 341 days
- Confirmation statement due
- 10 September 2027in 321 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Small
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2025 | −£297k | £192k | £2.27m | £3.70m | — | — | 51 |
| 31 December 2024 | £284k | £254k | £545k | £1.32m | — | — | 61 |
| 31 December 2023 | £923k | £889k | £720k | £1.37m | — | — | 56 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Filing and accounts signals
- Net assets below zeroNet assets £-296,682 at 31 December 2025
- Net assets down 25% or more on the prior period-204.3% vs prior period
- Current assets below creditors within one yearCurrent ratio 0.71
- Cash at bank of £50,000 or moreCash £191,814
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 27 August 2013
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 341 days
- Confirmation statement duein 321 days
- Accounts period endNet liabilities £297k · small accounts
- Accounts period endNet assets £284k · small accounts
- Accounts period endNet assets £923k · small accounts
- Incorporated
Similar companies in Manchester
- AKL RESEARCH & DEVELOPMENT LIMITEDManchester · inc. Sept 2013
- PCR MAX LIMITEDAltrincham · inc. Sept 2013
- INSECT RESEARCH SYSTEMS LTDNewton Le Willows · inc. Jul 2013
- SCOPE INTERNATIONAL (UK) LIMITEDBolton · inc. Apr 2013
- N2 PHARMACEUTICALS LTDBolton · inc. Apr 2013
- LCC THERAPEUTICS LTD.Warrington · inc. Feb 2014
All companies incorporated on 27 August 2013 · in Aug 2013.
Reminders for ALDERLEY ANALYTICAL LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.